Development of a high‐throughput scale‐down model in Ambr® 250 HT for plasmid DNA fermentation processes

Abstract

AbstractRecent advances in messenger ribonucleic acid (mRNA) vaccines and gene therapy vectors have increased the need for rapid plasmid DNA (pDNA) screening and production within the biopharmaceutical industry. High‐throughput (HT) fermentor systems, such as the Ambr® 250 HT, can significantly accelerate process development timelines of pDNA upstream processes compared to traditional bench‐scale glass fermentors or small‐scale steam‐in‐place (SIP) fermentors. However, such scale‐down models must be qualified to ensure that they are representative of the larger scale process similar to traditional small‐scale models. In the current study, we developed a representative scale‐down model of a Biostat® D‐DCU 30 L pDNA fermentation process in Ambr® 250 HT fermentors using three cell lines producing three different constructs. The Ambr scale‐down model provided comparable process performance and pDNA quality as the 30 L SIP fermentation process. In addition, we demonstrated the predictive value of the Ambr model by two‐way qualification, first by accurately reproducing the prior trends observed in a 30 L process, followed by predicting new process trends that were then successfully reproduced in the 30 L process. The representative and predictive scale‐down Ambr model developed in this study would enable a faster and more efficient approach to strain/clone/host‐cell screening, pDNA process development and characterization studies, process scale‐up studies, and manufacturing support.